More pathophysiologically oriented treatment of GORD?

Lancet

Volumn 359, Issue 9314, 2002, Pages 1267-1268

  Boeckxstaens, G E ^a   Tytgat, G N J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ACID; BACLOFEN; BILE ACID; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; GLUTAMATE RECEPTOR ANTAGONIST; MORPHINE; NITRIC OXIDE SYNTHASE INHIBITOR; PEPSIN A; PLACEBO; PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; BLOOD BRAIN BARRIER; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; DYSPLASIA; ESOPHAGITIS; ESOPHAGUS CARCINOMA; EXPOSURE; FATIGUE; FLATULENCE; GABAERGIC SYSTEM; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LOWER ESOPHAGUS SPHINCTER; LOWER ESOPHAGUS SPHINCTER PRESSURE; MECHANORECEPTOR; MUCOSA INFLAMMATION; NOTE; PATHOPHYSIOLOGY; PREGANGLIONIC NERVE CELL; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SOMNOLENCE; STOMACH ACID SECRETION; STOMACH DISTENSION; STOMACH EMPTYING; SWALLOWING; VAGUS NERVE; VERTIGO;

EID: 0037070753     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08285-5     Document Type: Note

References (14)

1. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication
2. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole
3. The esophagogastric junction
4. Transient lower oesophageal sphincter relaxations: A pharmacological target for gastro-oesophageal reflux disease?
5. Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects
6. Involvement of cholecystokininA receptors in transient lower esophageal sphincter relaxations triggered by gastric distension
7. Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation
8. Involvement of glutamate in transient lower esophageal sphincter relaxations
9. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis
10. Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs
11. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects
12. Receptors and transmission in the brain-gut axis: Potential for novel therapies IV: GABA(B) receptors in the brain-gastroesophageal axis
13. Site of action of GABA(B) receptor for vagal motor control of the lower esophageal sphincter in ferrets and rats
14. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease